Respiration最新文献

筛选
英文 中文
Successful Conversion of Collateral Ventilation Status Using the AeriSeal® System Enables Bronchoscopic Lung Volume Reduction with One-Way Valves: CONVERT Trial. 使用AeriSeal®系统成功转换侧支通气状态,实现单向阀支气管镜肺减气量:CONVERT试验
IF 2.6 3区 医学
Respiration Pub Date : 2026-11-16 DOI: 10.1159/res/aepag027
Michela Bezzi, Alvin J Ing, Thomas Egenod, Nicolas Guibert, Pallav L Shah, Samuel V Kemp, Felix Herth, Farzad Bashirzadeh, Ralf-Harto Hübner, Dirk-Jan Slebos, Alan Jb Kirk, Carolin Steinack, Daniel Franzen, Malgorzata Kornaszewska, James Tonkin, Karin Klooster, Guido Levi, Venere Piluso, Jonathan P Williamson, Tajalli Saghaie, Judith Maria Brock, Konstantina Kontogianni, Rocco Bilancia, Jacopo Saccomanno, Sri Radhakrishnan, Brian R Armstrong, Narinder S Shargill, Ruediger Karpf-Wissel, Kaid Darwiche
{"title":"Successful Conversion of Collateral Ventilation Status Using the AeriSeal® System Enables Bronchoscopic Lung Volume Reduction with One-Way Valves: CONVERT Trial.","authors":"Michela Bezzi, Alvin J Ing, Thomas Egenod, Nicolas Guibert, Pallav L Shah, Samuel V Kemp, Felix Herth, Farzad Bashirzadeh, Ralf-Harto Hübner, Dirk-Jan Slebos, Alan Jb Kirk, Carolin Steinack, Daniel Franzen, Malgorzata Kornaszewska, James Tonkin, Karin Klooster, Guido Levi, Venere Piluso, Jonathan P Williamson, Tajalli Saghaie, Judith Maria Brock, Konstantina Kontogianni, Rocco Bilancia, Jacopo Saccomanno, Sri Radhakrishnan, Brian R Armstrong, Narinder S Shargill, Ruediger Karpf-Wissel, Kaid Darwiche","doi":"10.1159/res/aepag027","DOIUrl":"https://doi.org/10.1159/res/aepag027","url":null,"abstract":"<p><strong>Rationale: </strong>Bronchoscopic lung volume reduction (BLVR) with endobronchial valves is effective primarily in patients without collateral ventilation (CV-), leaving limited options for patients with collateral ventilation (CV+) in the target lobe. AeriSeal, delivered bronchoscopically, may occlude collateral channels and enable subsequent valve treatment.</p><p><strong>Objectives: </strong>To prospectively evaluate whether AeriSeal can convert target lobes from CV+ to CV- status in severe emphysema, enabling subsequent treatment with Zephyr valves.</p><p><strong>Methods: </strong>Patients with severe COPD/emphysema, fissure completeness ≥80% on quantitative CT, and Chartis-confirmed collateral ventilation-positive (CV+) status were enrolled. Eligible subjects had fissure defects involving no more than three segmental airways. AeriSeal foam (≤40 mL) was administered bronchoscopically in one or two sessions, and CV status was reassessed after 6 weeks. Subjects converting to CV- status underwent Zephyr valve placement. Primary endpoints were successful CV conversion and target lobe volume reduction (TLVR ≥350 mL) 45 days after valve implantation.</p><p><strong>Measurements and main results: </strong>Among 101 subjects, 75/99 evaluable patients achieved CV conversion (75.8%; 95% exact CI, 66.1-83.8%). Following valve treatment, TLVR ≥350 mL was achieved in 64/72 evaluable subjects (88.9%; 95% exact CI, 79.3-95.1%), with mean TLVR of 1062.5 ± 676.2 mL at 45 days, sustained through 12 months. At 6 months, post-bronchodilator FEV₁ improved by 0.08 L, residual volume decreased by 0.49L, SGRQ improved by 6.4 points, and mMRC by 0.8 points. Common serious adverse events included post-acute inflammatory response (PAIR; 16.7%), pneumothorax (19.2% within 45 days post-valves), COPD exacerbation, and pneumonia. Three deaths occurred, including one probably valve-related.</p><p><strong>Conclusions: </strong>AeriSeal effectively converts collateral ventilation status in most treated patients, enabling successful valve therapy with durable lobar volume reduction and acceptable safety.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of oxygen delivery location during non-invasive home mechanical ventilation: a randomised cross-over simulation study. 无创家庭机械通气期间供氧位置的影响:一项随机交叉模拟研究。
IF 2.6 3区 医学
Respiration Pub Date : 2026-11-14 DOI: 10.1159/res/aepag028
Dario Somaini, Zoe Bousraou, Lara Benning, Silvia Ulrich, Martin Lüchinger, Esther I Schwarz
{"title":"Impact of oxygen delivery location during non-invasive home mechanical ventilation: a randomised cross-over simulation study.","authors":"Dario Somaini, Zoe Bousraou, Lara Benning, Silvia Ulrich, Martin Lüchinger, Esther I Schwarz","doi":"10.1159/res/aepag028","DOIUrl":"https://doi.org/10.1159/res/aepag028","url":null,"abstract":"<p><strong>Introduction: </strong>In non-invasive home mechanical ventilation (NIV) using single-limb circuits with vented masks, supplemental oxygen can be added at different locations, potentially resulting in variable delivered inspired oxygen fractions (FiO₂). Recommendations and data comparing oxygen inlet positions are lacking.</p><p><strong>Methods: </strong>A lung simulator study was conducted using a 1.8 m single-limb NIV circuit with a vented mask. Oxygen was added at three locations: the ventilator oxygen port, a bleed-in connector near the ventilator outlet, and a bleed-in connector between the tube and mask. Oxygen flow rates of 1, 2, and 3 L/min were tested. Three simulated conditions were studied by adjusting lung compliance and airway resistance: healthy, COPD, and obesity. NIV was applied in pressure-controlled ventilation mode. Settings were EPAP/IPAP 4/14 cmH₂O for the healthy model, and both 4/18 and 8/20 cmH₂O for the COPD and obesity models, with a respiratory rate of 14/min. Mean resulting FiO₂ and minute ventilation from three repeated measurements in random order were recorded.</p><p><strong>Results: </strong>Oxygen delivery via the ventilator oxygen-port and ventilator-near bleed-in produced broadly similar FiO2 values, ad both generally higher FiO₂ than mask-near delivery. Differences between inlet positions became more pronounced at higher oxygen flows reaching a maximum absolute difference of 5.3 percentage points between oxygen port an mask-near delivery. FiO₂ also differed between the two tested ventilator pressure settings in the COPD and obesity simulations, despite only small differences in minute ventilation. Increasing oxygen flow increased FiO₂ across all configurations, although the magnitude of this effect depended on oxygen-injection location and the simulated condition.</p><p><strong>Conclusion: </strong>In this lung simulator study using a single-limb NIV circuit with a vented mask, oxygen injection location influenced the achieved FiO₂. Under the tested conditions, oxygen delivery via the ventilator oxygen port and a ventilator-near bleed-in connector resulted in broadly similar FiO₂ values and generally achieved higher FiO₂ than mask-near delivery. These findings warrant validation across different ventilators, circuits, interfaces, and pressure settings.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Needle-based Confocal Laser Endomicroscopy (nCLE) for Tool-in-Lesion Confirmation in Cone-Beam CT-guided Navigation Bronchoscopy: a Prospective Concordance Study. 针基共聚焦激光内镜(nCLE)在锥形束ct引导下的导航支气管镜中用于病灶内工具的确认:一项前瞻性一致性研究。
IF 2.6 3区 医学
Respiration Pub Date : 2026-11-14 DOI: 10.1159/res/aepag029
Saskia van Heumen, Onno M Mets, Daniel M de Bruin, Peter I Bonta, Johannes M A Daniels, Marjolein A Heuvelmans, Jouke T Annema
{"title":"Needle-based Confocal Laser Endomicroscopy (nCLE) for Tool-in-Lesion Confirmation in Cone-Beam CT-guided Navigation Bronchoscopy: a Prospective Concordance Study.","authors":"Saskia van Heumen, Onno M Mets, Daniel M de Bruin, Peter I Bonta, Johannes M A Daniels, Marjolein A Heuvelmans, Jouke T Annema","doi":"10.1159/res/aepag029","DOIUrl":"https://doi.org/10.1159/res/aepag029","url":null,"abstract":"<p><strong>Background and objective: </strong>Positioning sampling instruments within pulmonary nodules remains a challenge during navigation bronchoscopy. Cone-beam computed tomography (CBCT) and needle-based confocal laser endomicroscopy (nCLE) enable tool positioning feedback. However, access to CBCT systems is limited and associated with radiation exposure. To date, no direct comparison between these two modalities has been reported. This study compares CBCT and nCLE for sampling tool position in navigation bronchoscopy for peripheral pulmonary nodules (PPNs).</p><p><strong>Methods: </strong>Twenty-five patients with PPNs scheduled for CBCT-guided navigation bronchoscopy were prospectively enrolled. nCLE imaging, CBCT image acquisition and needle aspiration were performed twice for each nodule, followed by (cryo)biopsies. nCLE videos were evaluated using validated criteria and categorized as tool-in-lesion (TIL) or tool-out-lesion (TOL). CBCT scans were classified as TIL, tool-in-contact (TIC), or TOL.</p><p><strong>Results: </strong>nCLE imaging was performed in 24 patients (nodule was not reached in one), with a median nodule diameter of 19 mm, yielding good-quality images in 22/24 patients (92%). In 77% of these cases, there was an agreement between nCLE and CBCT on the needle position. There were no cases in which CBCT confirmed TIL while nCLE did not. From the five discrepant cases, four were TIC on CBCT, while nCLE was TOL. In one case, there was a complete discrepancy between the techniques with nCLE as TIL and CBCT TOL.</p><p><strong>Conclusion: </strong>nCLE and CBCT offer complementary tool position information, with nCLE delivering microscopic-level insights and CBCT providing three-dimensional anatomical context. In environments where CBCT is not available, nCLE may serve as an alternative.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National Trends in Open vs Percutaneous Tracheostomy Among U.S. Hospitalizations for COPD Exacerbation, 2016-2022. 2016-2022年美国COPD急性加重住院患者中开放气管切开术与经皮气管切开术的全国趋势
IF 2.6 3区 医学
Respiration Pub Date : 2026-10-22 DOI: 10.1159/res/aepag024
Garry Francis Morel, Aditya Katyal, Setu Patolia, Ghassan Kamel
{"title":"National Trends in Open vs Percutaneous Tracheostomy Among U.S. Hospitalizations for COPD Exacerbation, 2016-2022.","authors":"Garry Francis Morel, Aditya Katyal, Setu Patolia, Ghassan Kamel","doi":"10.1159/res/aepag024","DOIUrl":"https://doi.org/10.1159/res/aepag024","url":null,"abstract":"<p><p>Background National utilization and short-term outcomes of open surgical tracheostomy (OST) versus percutaneous dilatational tracheostomy (PDT) in adults hospitalized for COPD exacerbation are uncertain. Methods Adult hospitalizations not coded as elective, with a primary diagnosis of COPD exacerbation and tracheostomy, in the U.S. National Inpatient Sample (2016-2022) were classified as OST or PDT using ICD-10-PCS approach codes. Utilization trends, in-hospital mortality, length of stay (LOS), and inflation-adjusted charges were compared using survey-weighted multivariable models and inverse probability of treatment weighting (IPTW), with further adjustment for timing, coded severity, and pandemic period. Results Of an estimated 2,970 hospitalizations (594 sampled), 36.5% involved PDT. Annual volumes declined for PDT (215 to 115; P-trend=0.023) and OST (480 to 165; P-trend=0.003). In-hospital mortality was 13.5% (PDT 14.3% vs OST 13.0%; P=0.662). Mortality was higher in 2020-2022 than in 2016-2019 among OST hospitalizations (21.3% vs 10.2%; P=0.006) but not among PDT hospitalizations (18.3% vs 12.7%; P=0.29); annual trends did not differ significantly between approaches (P for interaction=0.061). After adjustment, PDT was not associated with mortality (RR, 1.06; 95% CI, 0.68-1.66), LOS (-0.63 days; 95% CI, -4.19 to 2.94), or charges (ratio, 0.98; 95% CI, 0.85-1.12); estimates were consistent with IPTW, timing and severity adjustment, exclusion of 2020, and within both periods. Conclusions Both OST and PDT volumes declined. No significant association was detected between approach and short-term outcomes, although estimates were imprecise. The mortality increase within OST hospitalizations, concentrated in the pandemic period, warrants cautious interpretation given potential changes in case mix, treatment selection, pandemic-related practice, and unmeasured severity.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":"1"},"PeriodicalIF":2.6,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149246181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neural drive and respiratory muscle effort in emphysema following lung volume reduction. 肺气肿肺体积缩小后的神经驱动和呼吸肌用力。
IF 2.6 3区 医学
Respiration Pub Date : 2026-10-20 DOI: 10.1159/res/aepag023
Else A M D Ter Haar, Dirk-Jan Slebos, Marieke Leontine Duiverman, Linze J Dijkstra, Jorine E Hartman
{"title":"Neural drive and respiratory muscle effort in emphysema following lung volume reduction.","authors":"Else A M D Ter Haar, Dirk-Jan Slebos, Marieke Leontine Duiverman, Linze J Dijkstra, Jorine E Hartman","doi":"10.1159/res/aepag023","DOIUrl":"https://doi.org/10.1159/res/aepag023","url":null,"abstract":"<p><p>Introduction Respiratory muscle impairment is common in patients with severe emphysema, primarily driven by lung hyperinflation. Endobronchial valve (EBV) treatment reduces hyperinflation and may restore respiratory mechanics in this patient population. Our aim was to investigate changes in neural drive and respiratory muscle recruitment following EBV treatment. Methods EBV-eligible emphysema patients from our prior study on diaphragm function were prospectively enrolled (NCT04735731). Respiratory muscle activation and timing were assessed using surface electromyography at baseline and 6 weeks following EBV treatment. Additionally, an age-matched control group without respiratory symptoms was included for comparison. Results We included 25 patients who underwent EBV treatment (mean FEV1 28% predicted, mean RV 233% predicted) and 12 controls. The inspiratory time (Ti) to total time of respiratory cycle (Ttot) ratio (0.35 vs 0.53; p=0.003) was significantly lower in patients compared to controls. Activity of the diaphragm (4.7 vs 0.9 µV; p<0.001) and intercostal muscles (1.2 vs 0.4 µV; p<0.001) during tidal breathing was significantly higher in patients. Furthermore, tonic (end-expiratory) activity of the diaphragm (1.4 vs 0.6 µV; p=0.012) and intercostal muscles (1.4 vs 0.6 µV; p=0.003) was significantly higher as well. Following EBV treatment, all measured outcomes improved significantly, approaching the values observed in the control group. Conclusion These findings indicate that neural drive and respiratory muscle effort are significantly elevated in severe emphysema patients. By reducing lung hyperinflation, endobronchial valve treatment reduces this load, resulting in improved respiratory mechanics and decreased work of breathing, an important contributor to dyspnoea severity.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":"1"},"PeriodicalIF":2.6,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149228571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary Hypertension Associated With Lung Disease: An Expert Review From the Cologne Conference. 与肺部疾病相关的肺动脉高压——来自科隆会议的专家评论
IF 2.6 3区 医学
Respiration Pub Date : 2026-10-17 DOI: 10.1159/res/aepag019
Silvia Ulrich, Katrin Milger, Michael Halank, Hans Klose, Tobias J Lange, Hanno H Leuchte, Esther J Nossent, Hans-Jürgen Seyfarth, Oksana A Shlobin, Dirk Skowasch, Michael Dreher, Juergen Behr
{"title":"Pulmonary Hypertension Associated With Lung Disease: An Expert Review From the Cologne Conference.","authors":"Silvia Ulrich, Katrin Milger, Michael Halank, Hans Klose, Tobias J Lange, Hanno H Leuchte, Esther J Nossent, Hans-Jürgen Seyfarth, Oksana A Shlobin, Dirk Skowasch, Michael Dreher, Juergen Behr","doi":"10.1159/res/aepag019","DOIUrl":"10.1159/res/aepag019","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary hypertension (PH) associated with chronic lung disease (CLD) (PH_lung) is a frequent complication of chronic obstructive pulmonary disease (COPD), interstitial lung disease, and other parenchymal lung disorders, and is associated with impaired exercise capacity, reduced quality of life and poor survival. Despite increasing recognition of its clinical importance, major challenges remain regarding early diagnosis, hemodynamic classification, and optimal treatment.</p><p><strong>Summary: </strong>This review summarizes current concepts of the diagnosis and management of PH_lung, with particular emphasis on multimodal screening strategies integrating pulmonary function testing, biomarkers, echocardiography, cardiopulmonary exercise testing, and thoracic imaging to improve patient selection for right heart catheterization. We discuss practical aspects of hemodynamic assessment, overlapping phenotypes, including connective tissue disease, sarcoidosis, and the emerging pulmonary vascular \"lung phenotype,\" and current evidence supporting targeted therapies with emphasis on patients' pathways in real-world settings. While inhaled treprostinil has become the first approved treatment for PH associated with interstitial lung disease in some countries, no PH-specific therapy is currently recommended routinely for COPD-associated PH, highlighting the need for careful patient phenotyping and individualized management in expert centers. Earlier recognition, multidisciplinary collaboration, and continued translational and clinical research are essential to improve outcomes in this highly vulnerable patient population.</p><p><strong>Key messages: </strong>Patients with PH_lung may present in pulmonary clinics with worsening CLD or are diagnosed in the work-up of PH. PH_lung is a severe condition that should be managed in expert centers with the possibility of advanced therapies, including transplantation and inclusion in clinical trials.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":"1"},"PeriodicalIF":2.6,"publicationDate":"2026-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13713045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149216668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Performance and Safety Profile of Shape-Sensing Robotic-Assisted Bronchoscopy in Peripheral Pulmonary Lesions: A Systematic Review and Meta-Analysis. 形状传感机器人辅助支气管镜在周围性肺病变中的诊断性能和安全性:系统回顾和荟萃分析。
IF 2.6 3区 医学
Respiration Pub Date : 2026-10-10 DOI: 10.1159/res/aepag020
Xianya Hu, Lechen Wang, Jingyu Shi, Sebastian Fernandez-Bussy, Dan Liu
{"title":"Diagnostic Performance and Safety Profile of Shape-Sensing Robotic-Assisted Bronchoscopy in Peripheral Pulmonary Lesions: A Systematic Review and Meta-Analysis.","authors":"Xianya Hu, Lechen Wang, Jingyu Shi, Sebastian Fernandez-Bussy, Dan Liu","doi":"10.1159/res/aepag020","DOIUrl":"10.1159/res/aepag020","url":null,"abstract":"<p><strong>Introduction: </strong>Shape-sensing robotic-assisted bronchoscopy (ssRAB) has emerged as a promising modality for diagnosing peripheral pulmonary lesions. This meta-analysis evaluated its diagnostic performance and safety profile.</p><p><strong>Methods: </strong>PubMed, Embase, and Cochrane Library were searched from inception to December 2025. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-3. Random-effects model was used to estimate the pooled diagnostic yield, sensitivity for malignancy, and complication, with rates (%) and 95% confidence intervals (CI) when the I2 index exceeded 50%. Cumulative meta-analysis was performed to assess the temporal stability and evidence saturation of the pooled diagnostic yield. Publication bias was evaluated using funnel plots and Egger's test.</p><p><strong>Results: </strong>A total of 3,678 lesions from 18 studies were included. Notably, diagnostic yield varied significantly by outcome definition, with pooled diagnostic yield of 82.5% (95% CI: 78.3%-86.0%) under strict definition vs. 88.1% (95% CI: 82.8%-92.0%) under the intermediate definition (p = 0.036). The pooled sensitivity for malignancy of 90.0% (95% CI: 86.4%-92.8%). Cumulative meta-analysis showed stabilized diagnostic performance after approximately 1,500 lesions for the strict definition and 500 lesions for intermediate definition. Moreover, the safety profile was favorable, with pooled rates of pneumothorax of 1.8% (95% CI: 1.3%-2.3%), chest tube placement of 1.1% (95% CI: 0.7%-1.5%), and severe bleeding of 0.0% (95% CI: 0.0%-0.3%). Subgroup analyses showed consistent performance across study designs, region, and nodule characteristics. Diagnostic yield was significantly influenced by publication year and lesion size (p < 0.05).</p><p><strong>Conclusion: </strong>ssRAB was associated with favorable, definition-dependent diagnostic yield (82.5%-88.1%) with exceptional safety, supporting ssRAB as an attractive first-line minimally invasive diagnostic option in appropriately selected patients, especially for small nodules (<2 cm) and patients at elevated procedural risk.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":"1"},"PeriodicalIF":2.6,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149169866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Maximality Criteria of Cardiopulmonary Exercise Testing in Healthy Subjects and Patients with Chronic Respiratory Disease: A Practical Clinical Framework. 探索健康受试者和慢性呼吸系统疾病患者心肺运动试验的最大值标准:一个实用的临床框架。
IF 2.6 3区 医学
Respiration Pub Date : 2026-10-10 DOI: 10.1159/res/aepag004
Michaël Staes, Iwein Gyselinck, Maud Lormans, Marieke Wuyts, Thierry Troosters, Maarten De Vos, Wim Janssens
{"title":"Exploring Maximality Criteria of Cardiopulmonary Exercise Testing in Healthy Subjects and Patients with Chronic Respiratory Disease: A Practical Clinical Framework.","authors":"Michaël Staes, Iwein Gyselinck, Maud Lormans, Marieke Wuyts, Thierry Troosters, Maarten De Vos, Wim Janssens","doi":"10.1159/res/aepag004","DOIUrl":"10.1159/res/aepag004","url":null,"abstract":"<p><strong>Background: </strong>Incremental cardiopulmonary exercise testing (CPET) is used to assess exercise capacity and identify mechanisms of exercise limitation. Identification of test maximality is essential for correct interpretation, yet no consensus exists on the defining criteria. This study evaluated the performance of different <mml:math id=\"m1\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"normal\">V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant=\"normal\">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math> plateau definitions and the contribution of secondary maximality criteria in patients with chronic respiratory disease and healthy controls.</p><p><strong>Methods: </strong>We retrospectively analyzed 395 CPETs (84 healthy, 135 chronic obstructive pulmonary disease, 99 interstitial lung disease, 77 pulmonary hypertension), comparing consensus-based visual identification of a <mml:math id=\"m2\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"normal\">V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant=\"normal\">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math> plateau by three pulmonologists with three commonly used plateau definitions. Additionally, five secondary maximality criteria were evaluated, using strict and liberal thresholds.</p><p><strong>Results: </strong>The relative <mml:math id=\"m3\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"normal\">V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant=\"normal\">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math> plateau definition showed strong agreement with visual assessment (κ = 0.75-0.93), while absolute thresholds were discordant (κ = 0.02-0.31). Overlap between maximality criteria was high in healthy individuals but low in disease groups, suggesting that evaluating multiple criteria in parallel is necessary. However, combining more than 2 secondary criteria in healthy subjects and more than 3 in patients on top of <mml:math id=\"m4\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"><mml:mrow><mml:mover accent=\"true\"><mml:mi mathvariant=\"normal\">V</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:msub><mml:mi mathvariant=\"normal\">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math> plateau provided minimal additive value.</p><p><strong>Conclusion: </strong>CPET maximality assessment depends strongly on the criteria applied, potentially altering CPET interpretation and clinical decision-making.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":"1"},"PeriodicalIF":2.6,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13688374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149169707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival in Patients With Activity-Related Dyspnea: A Retrospective Cohort Study. 活动相关性呼吸困难患者的生存率。回顾性队列研究。
IF 2.6 3区 医学
Respiration Pub Date : 2026-10-08 DOI: 10.1159/res/aepag022
Carmen Wick, Helga Preiss, Michael Furian, Kay von Grünigen, Stéphanie Saxer, Julian Müller, Simon R Schneider, Malcolm Kohler, Silvia Ulrich, Mona Lichtblau
{"title":"Survival in Patients With Activity-Related Dyspnea: A Retrospective Cohort Study.","authors":"Carmen Wick, Helga Preiss, Michael Furian, Kay von Grünigen, Stéphanie Saxer, Julian Müller, Simon R Schneider, Malcolm Kohler, Silvia Ulrich, Mona Lichtblau","doi":"10.1159/res/aepag022","DOIUrl":"10.1159/res/aepag022","url":null,"abstract":"<p><strong>Introduction: </strong>In an aging and multimorbid population, activity-related dyspnea is frequent. The aim was to study the prognostic relevance of patient-reported dyspnea, independent of the underlying diseases.</p><p><strong>Methods: </strong>This retrospective cohort study included patients undergoing cardiopulmonary exercise tests for evaluation of activity-related dyspnea who had simultaneous assessment of dyspnea severity by the New York Heart Association (NYHA) functional class (I-III) or the modified Medical Research Council (mMRC) scale (0-3), which was harmonized into a unified dyspnea severity score (1: NYHA I and/or mMRC 0; 2: NYHA II and/or mMRC 1; 3: NYHA III and/or mMRC 2-3) for analysis. Survival analysis (Kaplan-Meier analysis, Cox proportional hazards model) was adjusted for age, sex, smoking status, exercise-induced desaturation, and number of cardiac and/or pulmonary diagnoses.</p><p><strong>Results: </strong>A total of 1,061 patients (56% female, 58 years, BMI: 26.3 kg/m2) were included of whom 48% had ≥2 cardiac/pulmonary diseases. The 1-/3-/5-year survival for dyspnea score was 1 99/96/94%, for dyspnea score was 2 98/93/89%, and for dyspnea score was 3 95/87/79% (p < 0.001 for overall group comparisons). Increasing age and male sex were independently associated with worse survival, while exercise desaturation, smoking status, and the number of cardiac/pulmonary diagnoses were not. The combination of dyspnea score 3 and exercise-induced desaturation or ≥2 cardiac/pulmonary diagnoses each had a 5-year survival of 73%.</p><p><strong>Conclusion: </strong>Activity-related dyspnea in cardiac/pulmonary diseases is independently associated with worse survival irrespective of the number of underlying diagnoses. These findings suggest that activity-related dyspnea may serve as a clinically relevant prognostic marker. Further validation in prospective cohorts is required.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":"1"},"PeriodicalIF":2.6,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging respiratory infectious diseases: Clinical aspects for rapid identification and management. 新出现的呼吸道传染病:临床方面的快速识别和管理。
IF 2.6 3区 医学
Respiration Pub Date : 2026-10-07 DOI: 10.1159/res/aepag021
Thierry Rolling, Thomas Theo Brehm, Florian Krammer, Marylyn Addo, Stefan Schmiedel, Helmut Salzer
{"title":"Emerging respiratory infectious diseases: Clinical aspects for rapid identification and management.","authors":"Thierry Rolling, Thomas Theo Brehm, Florian Krammer, Marylyn Addo, Stefan Schmiedel, Helmut Salzer","doi":"10.1159/res/aepag021","DOIUrl":"https://doi.org/10.1159/res/aepag021","url":null,"abstract":"<p><p>Emerging respiratory infectious diseases increasingly arise at the human-animal-environment interface and challenge clinicians with rapidly evolving diagnostic, therapeutic, and infection-control decisions. This narrative review summarizes clinically relevant viral and bacterial pathogens that may present as severe respiratory disease, but are easily mistaken for common community-acquired infections during early illness. We focus on zoonotic influenza A viruses, including contemporary H5N1, Middle East respiratory syndrome coronavirus (MERS-CoV), hantaviruses, Nipah virus, and inhalational bacterial threats such as anthrax, pneumonic plague, tularemia, and melioidosis. These infections may progress from non-specific symptoms to severe pneumonia, acute respiratory distress syndrome, shock, neurological complications, disseminated infection, or death. Timely recognition depends on careful assessment of travel, occupational and recreational exposures, animal contact, outbreak signals, and pathogen-specific syndromic clues. Multiplex molecular diagnostics can support early triage and exclusion of common pathogens, but targeted PCR, culture, serology, sequencing, and reference laboratory confirmation remain essential. Management requires prompt supportive care, appropriate isolation, public health notification, and pathogen-directed antimicrobial, antiviral, antitoxin, or prophylactic strategies where available. By integrating clinical presentation, diagnostics, treatment, vaccines, and One Health considerations, this review aims to translate knowledge on emerging infections into practical bedside preparedness.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":"1"},"PeriodicalIF":2.6,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149128537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书